Log in or Sign up for Free to view tailored content for your specialty!
Infection Control News
Pre-existing illness strongest indicator of risk for severe COVID-19 in children
ANAHEIM, Calif. — A study found that having a pre-existing comorbidity was the strongest indicator of risk for severe COVID-19 in children, according to data reported here.
VIDEO: Anne Schuchat, MD, encourages pediatricians to ‘please take care of yourselves’
ANAHEIM, Calif. — Anne Schuchat, MD, former principal deputy director of the CDC, has a message for pediatricians.
Log in or Sign up for Free to view tailored content for your specialty!
COVID-19 vaccines prevented more than 300K deaths among Medicare beneficiaries in 2021
In the United States, COVID-19 vaccinations may have prevented more than 650,000 hospitalizations and 300,000 deaths among Medicare beneficiaries in 2021, according to a new report from HHS.
COVID-19 boosters reduce symptom severity and duration
People who received a booster dose of the COVID-19 vaccine had reduced symptom severity and duration across delta and omicron variant predominance, according to data from the COVID-Out trial.
Study does not prove link between aluminum in childhood vaccines and asthma, experts say
Experts said a recently published study that found a possible association between aluminum in childhood vaccines and persistent asthma in early childhood did not prove there was a link.
Top in ID: Masking in health care facilities; COVID-19 risk in people with obesity
The CDC recently announced that it is no longer recommending universal masking in health care settings unless the facility is in an area of high COVID-19 transmission.
HHS expands pool of providers who can administer monkeypox vaccine
HHS Secretary Xavier Becerra has amended the Public Readiness and Emergency Preparedness Act declaration, expanding the pool of providers authorized to administer vaccines against smallpox and monkeypox.
Fewer than half of US adults plan to get flu vaccine despite warnings of a severe season
Following last year’s mild influenza season, U.S. officials are emphasizing the importance of influenza, pneumococcal and COVID-19 vaccinations as they expect a much more severe season in the weeks to come.
Clinical trial of antiviral for monkeypox goes forward as cases decline
Experts involved with an NIH trial of tecovirimat said that even as cases of monkeypox continue to decline nationally, it is important to establish whether the antiviral is effective against the infection.
Solving the riddles of long COVID
Although the general understanding of long COVID has improved in the past year, many questions about the persistent sequelae experienced by some people after an acute SARS-CoV-2 infection remain, according to experts.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read